People, Before Profits: India’s Patent Law Under Attack
The deal is one of a number of bilateral trade agreements underway between Europe and other developing countries that contain such potentially damaging provisions.
24 articles related to "Patent Disputes"
Background: DR-TB in South Africa Tuberculosis is the leading cause of death in South Africa, and the country has a growing epidemic of drug-resistant tuberculosis (DR-TB). Every year, approximately...
Op-eds & Articles – Last updated 01 July 2014
This 17th edition of Untangling the Web of Antiretroviral Price Reductions is a departure from recent previous years. For this edition, the methods of collecting information on the sources and prices...
Report – Last updated 15 July 2014
MSF response to European Parliament proposals of EU enforcement of European trademarks on goods in transit
Médecins Sans Frontières is deeply concerned about the position taken by the European Parliament allowing European Union enforcement of European trademarks on goods in transit, including...
Statements, Speeches, Letters – Last updated 24 February 2014
New Delhi/Geneva, 4 March 2013 – The verdict into German pharmaceutical company Bayer’s appeal against the grant of a compulsory licence has been issued by India’s Intellectual Property...
Statements, Speeches, Letters – Last updated 04 March 2013
Final hearings begin in Bayer's appeal against Indian move to allow production of more affordable cancer drug
Further compulsory licences on high-price patented medicines expected 18 January 2013 - This week, final hearings began in Chennai, India, in the appeal that German pharmaceutical company Bayer...
Statements, Speeches, Letters – Last updated 18 January 2013
Patent Information & Transparency : A Methodology for Patent Searches on Essential Medicines in Developing Countries
A report by UNDP, co-authored by MSF's Barbara Milani, lays out a four-step methodolgy for conducting patent searches in developing countries providing an inexpensive and pragmatic option to perform...
Report – Last updated 12 July 2012
17 September 2012 - India's Intellectual Property Appellate Board (IPAB) has dismissed Bayer’s request for a stay order against the compulsory licence granted by the Patent Controller...
Statements, Speeches, Letters – Last updated 17 September 2012
Novartis and Bayer are both charging exhorbitant prices for medicines in India as they continue their fight against the country's patent law that puts people over profits in the name of access to...
Web article – Last updated 11 September 2012
Médecins Sans Frontières (MSF) has learnt that India's Intellectual Property Appellate Board (IPAB) in Chennai has postponed hearing the appeal by German pharmaceutical company Bayer...
Statements, Speeches, Letters – Last updated 21 August 2012
Médecins Sans Frontières (MSF) has learnt this morning that final arguments in the Indian Supreme Court case of Novartis vs. Government of India has been re-scheduled for 11 September...
Web article – Last updated 22 August 2012